Published in Gene Therapy Weekly, January 12th, 2006
M.A. Stoff-Khalili and colleagues, University of Alabama, wrote, "The development of novel therapeutic strategies is imperative for the treatment of advanced cancers like ovarian cancer and glioma, which are resistant to most traditional treatment modalities. In this regard, adenoviral (Ad) cancer gene therapy is a promising approach."
"However, the gene delivery efficiency of human serotype 5 recombinant Ad5 in cancer gene therapy clinical trials to date has...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.